Esperion Therapeutics ESPR

$ 2.49 3.32%

Quarterly report 2024-Q3
added 11-07-2024

Esperion Therapeutics EV/EBITDA Ratio 2011-2024 | ESPR

Annual EV/EBITDA Ratio Esperion Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-2.15	-5.97	-14.2	-5.73	-9.96	-2.82	-5.11	-18.6	-3.17	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-2.15	-18.6	-7.52